Neurology Alert (Vol. 35, No. 11) - July 1, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: July 2016

Valid through: July 2019

Target Audience

This activity is intended for the neurologist.

Subjects

  • Treatment of Glioblastoma in Elderly Patients
  • Do Miller Fisher Syndrome, Guillain-Barré Syndrome, and Bickerstaff Encephalitis Overlap?
  • Greater Weight Loss Later in Life Is Associated with Increased Risk of Mild Cognitive Impairment
  • Blood-Based Biomarkers in the Evaluation of Alzheimer’s Disease
  • Epidemiology of Neuromyelitis Optica Spectrum Disorders in Two Distinct Populations: Black and White
  • Dual Antiplatelet Therapy Appears More Effective Than Single Therapy
  • Which Patients with TIA are at High Risk for a Recurrent Cerebral Vascular Events?
  • Cerebral Microbleeds Are Risk Factor for Symptomatic Intracerebral Hemorrhage in Patients Undergoing IV Thrombolysis

Objectives

  • Discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • Discuss the pathogenesis and treatment of pain
  • Describe the basic science of brain function
  • Discuss new information regarding new drugs for commonly diagnosed neurological conditions

Credit Available

Physicians

  • Maximum of 2.25 AMA PRA Category 1 Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Rajiv S. Magge, MD, Assistant Professor of Neurology, Weill Cornell Brain Tumor Center

Michael Rubin, MD, Professor of Clinical Neurology, Weill Cornell Medical College

Makoto Ishii, MD, PhD, Assistant Professor of Neuroscience and Neurology, Feil Family Brain and Mind Research Institute, Department of Neurology, Weill Cornell Medical College

Michael T. Lin, MD, Associate Professor of Neurology and Neuroscience, Weill Cornell Medical College

Jai S. Perumal, MD, Assistant Professor of Neurology, Weill Cornell Medical College

Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

Editors

Medical Editor: Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

AHC Media Executive Editor: Leslie G. Coplin

Managing Editor: Jonathan Springston

Financial Disclosure

Author Jai S. Perumal, MD reports she receives grant/research support from Genzyme Corp., and is on the speakers bureau for Biogen Idec, Genzyme Corp., Acorda Therapeutiscs, and Teva Pharmaceuticals.

Authors Rajiv S. Magge, MD; Michael Rubin, MDMakoto Ishii, MD, PhD; and Michael T. Lin, MD; report no financial relationships relevant to this field of study.

Neurology Alert's editor in chief, Matthew E. Fink, MD reports he is a retained consultant for Procter & Gamble and Pfizer. Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and associate managing editor Jonathan Springston report no financial relationships relevant to this field of study.

Copyright 2016, AHC Media. All rights reserved.